Back to Blog
Dr. Dvanajscak Takes the MYMP
Dr. Dvanajsack was a part of a team of physicians who published a paper discussing how resistant starch (RS) improves CKD outcomes. In this report, the physicians study how RS modulates host‐microbiome interactions in CKD by measuring changes in the abundance of proteins and bacteria in the gut.
Read the Paper: Resistant Starch Slows the Progression of CKD in the 5/6 Nephrectomy Mouse Model
Who will take the MYMP next?
Quick note: This post is to be used for informational purposes only and does not constitute medical or health advice. Each person should consult their own doctor with respect to matters referenced. Arkana Laboratories assumes no liability for actions taken in reliance upon the information contained herein.